“Vessel co-option mediates resistance to anti-angiogenic therapy in liver metastases”

Where: At the Research Institute of the McGill University Health Centre (RI-MUHC) Glen Site, RI Auditorium, E.S1-1129, 1001 Decarie Boulevard, Montreal, Quebec, H4A 3J1

When: April 25, 2017, 4:00-5:00pm

Guest Speaker:
Peter Metrakos, MD, CM, FRCSC, FACS
Professor of Surgery, Pathology and Anatomy, McGill University
Principal Investigator and Program Leader, Cancer Research Program (CRP) – RI-MUHC

Presentations will be in English
For more information please contact: veronica.atehortua@muhc.mcgill.ca